Last reviewed · How we verify

NCT03675620

Blood Flow Restriction Training Following Glenoid Labral Repair

Withdrawn NA Last updated 6 February 2024
What this trial tests

NA trial testing BFR in Glenoid Labrum Tear. Withdrawn.

Timeline
31 January 2019
Primary endpoint
7 December 2022
7 December 2022

Quick facts

Lead sponsorAndrews Research & Education Foundation
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Start date31 January 2019
Primary completion7 December 2022
Estimated completion7 December 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Andrews Research & Education Foundation

Who can join

Adults 18 to 55, any sex, with Glenoid Labrum Tear. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to evaluate the effects of BFR training on patient reported outcome measures and shoulder muscle girth in patients following glenoid labral repair. The investigators hypothesize that participants receiving BFR with rehabilitation will have greater improvements in patient reported outcome measures and shoulder muscle girth than participants who are treated without BFR.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of BFR

Trials testing the same drug.

Other Andrews Research & Education Foundation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03675620.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing